TME Pharma N.V. (ALTME.PA)
EUR 0.06
(-3.88%)
EUR 0.06
(-3.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.34 EUR | 88.51% |
| 2022 | -11.66 EUR | 41.26% |
| 2021 | -19.85 EUR | 31.9% |
| 2020 | -29.15 EUR | -317.02% |
| 2019 | -6.99 EUR | 97.41% |
| 2018 | -269.77 EUR | -6.38% |
| 2017 | -253.59 EUR | 62.19% |
| 2016 | -670.77 EUR | 16.46% |
| 2015 | -802.97 EUR | -16.7% |
| 2014 | -688.08 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.12 EUR | 0.0% |
| 2023 Q4 | -0.23 EUR | 25.81% |
| 2023 FY | - EUR | 88.51% |
| 2023 Q1 | -0.54 EUR | 78.57% |
| 2023 Q2 | -0.54 EUR | 0.0% |
| 2023 Q3 | -0.31 EUR | 42.59% |
| 2022 Q3 | -1.65 EUR | 84.13% |
| 2022 Q2 | -10.40 EUR | -81.18% |
| 2022 FY | - EUR | 41.26% |
| 2022 Q1 | -5.74 EUR | 41.55% |
| 2022 Q4 | -2.52 EUR | -52.73% |
| 2021 Q3 | -5.43 EUR | 45.86% |
| 2021 Q2 | -10.03 EUR | -81.05% |
| 2021 FY | - EUR | 31.9% |
| 2021 Q1 | -5.54 EUR | 35.73% |
| 2021 Q4 | -9.82 EUR | -80.85% |
| 2020 Q3 | -5.37 EUR | 77.08% |
| 2020 FY | - EUR | -317.02% |
| 2020 Q4 | -8.62 EUR | -60.52% |
| 2020 Q1 | -12.93 EUR | -270.36% |
| 2020 Q2 | -23.43 EUR | -81.21% |
| 2019 FY | - EUR | 97.41% |
| 2019 Q4 | 7.59 EUR | 80.71% |
| 2019 Q3 | 4.20 EUR | 123.85% |
| 2019 Q2 | -17.61 EUR | -35.85% |
| 2019 Q1 | -12.96 EUR | 61.21% |
| 2018 Q3 | -33.42 EUR | 62.03% |
| 2018 Q4 | -33.42 EUR | 0.0% |
| 2018 Q2 | -88.02 EUR | 0.0% |
| 2018 Q1 | -88.02 EUR | -22.49% |
| 2018 FY | - EUR | -6.38% |
| 2017 Q3 | -71.86 EUR | -29.31% |
| 2017 Q1 | -55.57 EUR | 30.97% |
| 2017 Q2 | -55.57 EUR | 0.0% |
| 2017 Q4 | -71.86 EUR | 0.0% |
| 2017 FY | - EUR | 62.19% |
| 2016 Q1 | -286.07 EUR | -26.06% |
| 2016 FY | - EUR | 16.46% |
| 2016 Q4 | -80.50 EUR | 0.0% |
| 2016 Q2 | -286.07 EUR | 0.0% |
| 2016 Q3 | -80.50 EUR | 71.86% |
| 2015 Q1 | -202.97 EUR | 0.0% |
| 2015 Q3 | -226.94 EUR | -8.87% |
| 2015 FY | - EUR | -16.7% |
| 2015 Q4 | -226.94 EUR | 0.0% |
| 2015 Q2 | -208.44 EUR | -2.7% |
| 2014 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -1016.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 60.933% |
| Adocia SA | -1.91 EUR | 29.843% |
| Aelis Farma SA | -0.39 EUR | -243.59% |
| Biophytis S.A. | -12.55 EUR | 89.323% |
| Advicenne S.A. | -0.67 EUR | -100.0% |
| genOway Société anonyme | 0.17 EUR | 888.235% |
| IntegraGen SA | -0.03 EUR | -5073.745% |
| Medesis Pharma S.A. | -0.80 EUR | -67.5% |
| Neovacs S.A. | -0.00 EUR | -53500.0% |
| NFL Biosciences SA | -0.46 EUR | -191.304% |
| Plant Advanced Technologies SA | 0.07 EUR | 2014.286% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -1372.527% |
| Sensorion SA | -0.17 EUR | -688.235% |
| Theranexus Société Anonyme | -0.88 EUR | -52.273% |
| Valbiotis SA | -0.59 EUR | -127.119% |
| TheraVet SA | -0.49 EUR | -173.469% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -793.333% |
| DBV Technologies S.A. | -0.71 EUR | -88.732% |
| Genfit S.A. | -0.58 EUR | -131.034% |
| GeNeuro SA | -0.59 EUR | -127.119% |
| Innate Pharma S.A. | -0.09 EUR | -1324.017% |
| Inventiva S.A. | -2.43 EUR | 44.856% |
| MaaT Pharma SA | -1.73 EUR | 22.543% |
| MedinCell S.A. | -0.88 EUR | -52.273% |
| Nanobiotix S.A. | -1.08 EUR | -24.074% |
| OSE Immunotherapeutics SA | -1.18 EUR | -13.559% |
| Poxel S.A. | -0.91 EUR | -47.253% |
| GenSight Biologics S.A. | -0.54 EUR | -148.148% |
| Transgene SA | -0.22 EUR | -509.091% |
| Valneva SE | -0.73 EUR | -83.562% |